The authors of One more paper described the administration of HBOT as adjuvant therapy for acute macular neuroretinopathy in systemic lupus erythematosus in conjunction with immunosuppression in two patients [eleven].We only use top quality, credible resources to make certain content material accuracy and integrity. You may learn more about how we